This HTML5 document contains 120 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1038/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37287456
rdf:type
wikibase:Item
schema:description
article scientifique vedecký článok article científic مقالة علمية نشرت في 30 يونيو 2009 artigo científico scientific article published on 30 June 2009 vědecký článek bilimsel makale videnskabelig artikel vetenskaplig artikel artículu científicu espublizáu en 2009 наукова стаття, опублікована в червні 2009 articolo scientifico wissenschaftlicher Artikel wetenschappelijk artikel научни чланак
p:P577
wds:Q37287456-0FA6410B-4A4E-4741-BFC5-A93D045983ED
wdt:P577
2009-06-30T00:00:00Z
p:P407
wds:Q37287456-8765C53B-BD25-4437-97B4-596AB9C83B43
wdt:P407
wd:Q1860
p:P2888
wds:Q37287456-A0908418-555B-41A3-B6D8-6642CCE1C26F
wdt:P2888
n12:sj.bjc.6605157
p:P2860
wds:Q37287456-E141D465-56B8-41CB-B614-541542D18A45 wds:Q37287456-E7361609-9DC8-42AC-A71C-BA5A009D2348 wds:Q37287456-17EE8E4B-DBFD-4895-BF57-A618CB7A53F7 wds:Q37287456-17F75381-1738-4D0C-AF7A-A7A4246F19DE wds:Q37287456-055818E7-E1BB-45F5-B1E0-8806E056725F wds:Q37287456-85492180-2C06-4295-9665-1B635518FE9E wds:Q37287456-8562D8F0-DBBD-44BF-AF38-5020A279A7F3 wds:Q37287456-6664867B-AB65-45A1-8B70-F8626D73BC7D wds:Q37287456-7199092C-B5AB-4EE5-ABD1-E15018B15D1F wds:Q37287456-399A2EBC-D558-4CE6-AC89-479AE9BBA208 wds:Q37287456-435327EE-EB39-4361-B145-A7DB74699DDF wds:Q37287456-28C91054-2808-45B0-AB15-7BBBAEB75F14 wds:Q37287456-322DFEEF-5043-4362-A828-3B4EEC24FC56 wds:Q37287456-C705137E-0B2A-4856-9275-272ECE84CD36 wds:Q37287456-CE563CF5-E9E6-4514-B33C-698A5C621C82 wds:Q37287456-CF9DB52D-A684-4EF9-B0D8-FA8E00F56694 wds:Q37287456-AD372471-3183-49AC-844D-42343D5FB5F6 wds:Q37287456-B415E6AE-1FC4-43A5-877B-4CE16A49673D wds:Q37287456-9B1108F7-EF78-4AB6-9C36-572BD2A0B522 wds:Q37287456-8865EEDB-1443-448F-AAC1-9737856ADEE3 wds:Q37287456-93A70381-5C8D-46C5-BCB7-1F25753EE7F8
wdt:P2860
wd:Q47414890 wd:Q80300655 wd:Q80199944 wd:Q46974234 wd:Q53615310 wd:Q27860904 wd:Q46138913 wd:Q71215858 wd:Q41621972 wd:Q36933927 wd:Q44680178 wd:Q63199203 wd:Q53939205 wd:Q80070141 wd:Q79615897 wd:Q34593498 wd:Q40817506 wd:Q74645088 wd:Q68810527 wd:Q73691527 wd:Q41671863
p:P2093
wds:Q37287456-B80E5144-2B78-4A26-9E58-90871E7990B0 wds:Q37287456-9F946F96-5411-4009-9DA5-D191C5922696 wds:Q37287456-7858CAB2-C058-430F-B895-602B71A64D7B wds:Q37287456-7942AB29-EFBC-4ADD-85FE-249EFA7A3B1D wds:Q37287456-1D9371A3-0007-4233-BC48-84EA639C7E63 wds:Q37287456-453108AD-6C77-46D8-87A3-D3FA568961AF wds:Q37287456-DBF12DD2-FACC-48B2-8FED-C921BBBC07A1 wds:Q37287456-D20A2692-5E92-4BF4-8802-D2A9ED839527
wdt:P2093
P Neven B Van Calster I Vandenput A Capoen P Berteloot F Amant Ph Moerman K Leunen
rdfs:label
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread
skos:prefLabel
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
schema:name
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment? Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread
p:P50
wds:Q37287456-D48BCB37-449F-48E9-BD8D-0CDC90F0D07B
wdt:P50
wd:Q89808263
p:P1476
wds:Q37287456-C5DF8E61-17DF-4241-834A-A13DF33B3020
wdt:P1476
Neoadjuvant chemotherapy followed by interval debulking surgery in patients with serous endometrial cancer with transperitoneal spread (stage IV): a new preferred treatment?
p:P304
wds:Q37287456-A4970154-7186-49F7-B766-F008426CF759
wdt:P304
244-249
p:P31
wds:Q37287456-B3324EEC-3291-42DD-9241-9DA87EC7FA95
wdt:P31
wd:Q13442814
p:P921
wds:Q37287456-025BD9FE-5DD3-421C-9EBC-3AB31FC83394 wds:Q37287456-6827C85A-58B8-4EE6-81E2-2CBBAB261A74 wds:Q37287456-870E4DB1-A402-4767-B3F1-FFC39E2B7D3D
wdt:P921
wd:Q974135 wd:Q108855558 wd:Q944777
p:P698
wds:Q37287456-8807C939-6321-4803-AAC2-79D49E65BF99
wdtn:P698
n11:19568245
wdt:P698
19568245
p:P1433
wds:Q37287456-E3673CBB-794B-465B-8991-61E4F8CA361F
wdt:P1433
wd:Q326309
p:P433
wds:Q37287456-2DF0EC8D-EEC5-4CDA-A77C-D514F8A360C9
p:P478
wds:Q37287456-F0930AD4-FFD1-4A51-9DAC-5F2AFA003DC6
wdt:P433
2
wdt:P478
101
p:P356
wds:Q37287456-E111D210-A4AE-4925-8FDB-C8F1A46F3521
wdtn:P356
n9:SJ.BJC.6605157
wdt:P356
10.1038/SJ.BJC.6605157
p:P5875
wds:Q37287456-10D50C8C-EDAA-44F3-8F51-6D3BF87CDA6A
wdt:P5875
26332097
p:P932
wds:Q37287456-3B842BFA-BBC6-4165-A552-C5675C7D624F
wdt:P932
2720217